Induced cell morphology electroporation
US12083339B2 · kind B2 · utility
0Cited by
0References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 6, 2017 |
| Grant date | Sep 10, 2024 |
| Priority date | — |
| Expiry date | Oct 12, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/1793
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are methods of electroporation that can include the steps of contacting a cell that is responsive to an EphA2 receptor ligand with an amount of an EphA2 receptor ligand and applying high-frequency irreversible electroporation to the cell. Also described herein are methods of treating cancer in a subject in need thereof, wherein the methods can include the steps of administering an amount of an EphA2 receptor ligand and applying high-frequency irreversible electroporation to a location on or within the subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.